System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Wolfgang Retz is an expert in Psychiatry at University Medical Center of the Johannes Gutenberg University Mainz (Germany). As of October 2026, ScienceLeadR ranks Wolfgang Retz in the top 1% of experts worldwide for Attention Deficit Disorder with Hyperactivity. Wolfgang Retz has authored 170 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 2 of them ongoing. SLR score: 464 (community average: 125). How the SLR is computed.

LeadR Profile

Wolfgang Retz University Medical Center of the Johannes Gutenberg University Mainz Germany
464 ScienceLeadR Reputation 464

Unlock

Register Login
Network Map

Psychiatry

Subspecialties: Pediatrics - Public Health - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1995 - 2026
Source: PubMed

Saarland University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 170

Citations

Citations: 6 595 1st author: 32 Last author: 41 Unique author: 1

Main journals

Eur Arch Psychiatry Clin Neurosci 15
J Neural Transm (Vienna) 12
Nervenarzt 11
Fortschr Neurol Psychiatr 9
Atten Defic Hyperact Disord 6

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Neuropsychobiological transdiagnostic risk mechanisms for aggression in mental disorders across the life span.
PMID 42816837 — mental disorders, aggression		BMC Psychiatry20261
Cannabinoid type 1 receptor availability imaging in attention-deficit/hyperactivity disorder using [ 18F]MK-9470 positron emission tomography: study protocol of the CB1-ADHD study.
PMID 42728455 — methylphenidate, tomography, positron-emission tomography, brain, prefrontal cortex, endocannabinoids, therapeutics, impulsive behavior, cannabinoids, attention deficit disorder with hyperactivity		EJNMMI Rep20260
Epidemiology of aggression and violence in mental disorders and the approach of TRR 379.
PMID 42678543 — psychosomatic medicine, epidemiology, mental disorders, aggression, neurology		Nervenarzt20261
Efficacy of a stepped-care approach for school-age children with mild to moderate ADHD (ESCAschool-moderate): an adaptive intervention study including a randomized controlled trial.
PMID 42571030 — schools, signs and symptoms, behavior therapy, therapeutics, child, attention deficit disorder with hyperactivity, non-responder, partial responder		Child Adolesc Psychiatry Ment Health20260
The long-term impact of adverse childhood experiences on externalizing aggressiveness: sensitive periods during childhood and adolescence.
PMID 42038066 — aggression, life change events, adverse childhood experiences		Front Child Adolesc Psychiatry20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1
Phase 2 1
Phase 3 1

By status:

Not yet recruiting 2
Completed 1

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A prospective multicentre randomised double dummy double blind placebo controlled 3 way Phase III study to investigate the efficacy and safety of two dexamfetamine sulfate formulations in adults with ADHD DEXINA
2022-502903-31-00 — safety, dextroamphetamine, multiple chronic conditions, attention deficit disorder with hyperactivity		Phase 3Not yet recruiting2024
CBT for Adult Inmates With ADHD
NCT06080373 — time management, neurobiology, psychotherapy, criminal behavior, social skills, maintenance, signs and symptoms, prisons, risk factors, therapeutics, cognitive behavioral therapy, emotional regulation, attention deficit disorder with hyperactivity, cognitive restructuring		N/ANot yet recruiting2027

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS